Table II.F.32 Percent of private-sector employees enrolled in a health insurance plan that had a prescription drug coinsurance for generic, preferred, non-preferred, and specialty tiers by selected characteristics: United States, 2020
Division and State Generic Preferred Non-Preferred Specialty
United States 20.2%    30.6%    32.6%    41.2%   
New England:
Connecticut 20.1%    37.9%    45.4%    57.3%   
Maine 13.4%    23.8%    28.0%    48.6%   
Massachusetts 14.5%    22.3%    22.8%    30.9%   
New Hampshire 20.3%    28.5%    37.6%    39.3%   
Rhode Island 17.7%    23.9%    25.3%    29.5%   
Vermont 11.5%    24.2%    31.8%    28.9%   
Middle Atlantic:
New Jersey 27.0%    34.8%    34.1%    41.0%   
New York 12.6%    23.7%    25.4%    31.1%   
Pennsylvania 16.9%    29.1%    32.0%    35.2%   
East North Central:
Illinois 27.5%    38.1%    40.0%    37.8%   
Indiana 26.7%    34.1%    41.0%    50.5%   
Michigan 13.6%    21.8%    26.5%    44.7%   
Ohio 26.1%    31.3%    35.6%    46.2%   
Wisconsin 26.2%    34.5%    35.5%    40.0%   
West North Central:
Iowa 25.0%    34.0%    35.1%    35.8%   
Kansas 21.0%    27.0%    27.2%    40.0%   
Minnesota 30.0%    35.4%    34.9%    41.4%   
Missouri 18.9%    27.7%    29.3%    35.5%   
Nebraska 24.4%    31.6%    32.8%    36.7%   
North Dakota 24.3%    36.3%    39.2%    40.0%   
South Dakota 15.7%    30.5%    32.7%    36.7%   
South Atlantic:
Delaware 26.4%    39.1%    40.4%    35.3%   
District of Columbia 16.0%    28.1%    29.2%    50.2%   
Florida 17.7%    31.9%    31.9%    34.6%   
Georgia 14.4%    32.8%    31.9%    47.6%   
Maryland 17.0%    20.9%    22.2%    37.4%   
North Carolina 23.0%    36.2%    40.9%    46.5%   
South Carolina 20.1%    27.3%    32.0%    39.4%   
Virginia 21.0%    29.8%    33.6%    48.6%   
West Virginia 30.1%    36.2%    39.0%    56.3%   
East South Central:
Alabama 6.1%    13.0%    13.8%    26.4%   
Kentucky 29.0%    32.9%    32.6%    63.2%   
Mississippi 11.6%    21.4%    17.3%    22.4%   
Tennessee 26.7%    37.1%    39.3%    31.9%   
West South Central:
Arkansas 20.9%    28.4%    30.0%    27.3%   
Louisiana 13.7%    20.7%    22.1%    44.4%   
Oklahoma 15.4%    27.7%    29.7%    34.9%   
Texas 19.2%    31.9%    33.5%    32.2%   
Mountain:
Arizona 25.8%    40.3%    41.3%    35.7%   
Colorado 24.5%    30.8%    31.5%    40.1%   
Idaho 29.1%    41.7%    45.5%    48.0%   
Montana 19.0%    23.2%    30.3%    34.2%   
Nevada 16.1%    33.3%    34.0%    41.1%   
New Mexico 20.1%    23.8%    24.7%    47.9%   
Utah 22.8%    41.8%    46.5%    54.0%   
Wyoming 31.0%    45.0%    48.4%    50.1%   
Pacific:
Alaska 32.4%    42.8%    49.1%    63.0%   
California 15.4%    26.6%    27.5%    50.9%   
Hawaii 12.1%    24.1%    24.0%    30.0%   
Oregon 29.3%    38.5%    47.7%    65.1%   
Washington 36.2%    45.1%    52.3%    50.9%   

Source: Agency for Healthcare Research and Quality, Center for Financing, Access and Cost Trends. 2020 Medical Expenditure Panel Survey-Insurance Component.

Note: Definitions and descriptions of the methods used for this survey can be found in the Technical Appendix.

 

Table II.F.32 Standard errors for Percent of private-sector employees enrolled in a health insurance plan that had a prescription drug coinsurance for generic, preferred, non-preferred, and specialty tiers by selected characteristics: United States, 2020
Division and State Generic Preferred Non-Preferred Specialty
United States 0.56%    0.68%    0.68%    0.69%   
New England:
Connecticut 2.42%    2.74%    2.93%    3.35%   
Maine 2.58%    3.89%    4.34%    6.32%   
Massachusetts 3.21%    3.64%    3.63%    3.49%   
New Hampshire 2.90%    3.19%    3.62%    3.59%   
Rhode Island 3.60%    3.89%    3.92%    3.86%   
Vermont 1.95%    2.72%    3.59%    2.80%   
Middle Atlantic:
New Jersey 5.04%    5.05%    5.03%    5.06%   
New York 1.62%    2.35%    2.42%    2.55%   
Pennsylvania 2.27%    3.03%    3.11%    3.17%   
East North Central:
Illinois 2.79%    3.07%    3.00%    3.08%   
Indiana 3.30%    3.49%    3.68%    3.45%   
Michigan 2.04%    2.66%    2.83%    3.33%   
Ohio 3.64%    3.76%    4.11%    4.12%   
Wisconsin 3.30%    3.95%    3.95%    3.84%   
West North Central:
Iowa 2.73%    3.11%    3.15%    3.27%   
Kansas 3.15%    3.18%    3.13%    3.69%   
Minnesota 2.81%    2.95%    2.98%    4.22%   
Missouri 2.54%    3.34%    3.40%    3.01%   
Nebraska 2.78%    3.60%    3.62%    3.75%   
North Dakota 2.56%    3.26%    3.26%    3.36%   
South Dakota 2.47%    4.11%    4.06%    4.10%   
South Atlantic:
Delaware 5.69%    4.97%    4.86%    5.16%   
District of Columbia 2.80%    3.05%    2.94%    3.60%   
Florida 2.61%    3.21%    3.23%    3.33%   
Georgia 3.17%    4.34%    4.31%    4.71%   
Maryland 2.92%    3.00%    3.02%    3.72%   
North Carolina 3.68%    4.03%    3.94%    3.65%   
South Carolina 3.01%    3.26%    4.23%    4.19%   
Virginia 3.51%    4.22%    4.52%    4.74%   
West Virginia 3.28%    3.71%    3.91%    3.78%   
East South Central:
Alabama 1.24%    2.39%    2.43%    4.56%   
Kentucky 3.84%    3.96%    3.94%    4.15%   
Mississippi 1.86%    3.66%    2.27%    2.73%   
Tennessee 3.75%    4.16%    4.22%    3.92%   
West South Central:
Arkansas 3.66%    3.82%    3.51%    3.64%   
Louisiana 2.50%    2.85%    3.06%    4.20%   
Oklahoma 3.06%    3.72%    3.75%    3.80%   
Texas 2.02%    2.49%    2.51%    2.42%   
Mountain:
Arizona 7.57%    9.21%    9.05%    6.33%   
Colorado 3.46%    3.83%    3.84%    4.08%   
Idaho 5.45%    5.65%    5.56%    4.87%   
Montana 3.57%    3.41%    3.90%    3.70%   
Nevada 2.71%    3.66%    3.61%    3.92%   
New Mexico 3.65%    3.73%    3.77%    3.95%   
Utah 3.07%    3.30%    3.36%    3.48%   
Wyoming 3.79%    4.65%    4.38%    4.48%   
Pacific:
Alaska 3.08%    4.47%    4.47%    4.36%   
California 1.85%    2.77%    2.64%    2.90%   
Hawaii 2.97%    3.56%    3.51%    3.52%   
Oregon 3.19%    3.62%    3.76%    3.47%   
Washington 4.30%    4.29%    4.03%    4.12%   

Source: Agency for Healthcare Research and Quality, Center for Financing, Access and Cost Trends. 2020 Medical Expenditure Panel Survey-Insurance Component.

Note: Definitions and descriptions of the methods used for this survey can be found in the Technical Appendix.